Quarterly Financial Report Q1_2012

Highlights – 1st Quarter 2012

Organic sales growth of 1.2% driven by Merck Serono and Merck Millipore, offsetting declines in Performance Materials and Consumer Health
EBITDA pre one-time items declines by 8.4% to € 675 million from € 737 million versus a very strong year-ago quarter
Group-wide restructuring process well underway
Sales
EBITDA pre one-time items
by quarter€ million
Merck Group | Sales by quarter (bar chart)

SERVICES

DOWNLOADS

Download PDF (1.6 MB) Download XLS (0.1 MB)

ANNUAL REPORT 2011

Read the Annual Report online
 
Imprint, © Merck KGaA, Darmstadt, Germany, Last Update 2012/05/15